BVT 2733

CAT: 0804-HY-18054-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-18054-01Size:5 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BVT 2733 is a potent, selective, and orally active non-steroidal 11β-hydroxydehydrogenase 1 (11β-HSD1) inhibitor. BVT 2733 is potently against the mouse enzyme (IC50=96 nM) over the human enzyme (IC50=3341 nM) . BVT 2733 has the potential for the study of arthritis and obesity related disease[1].
CAS Number
[376640-41-4]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
11β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/BVT-2733.html
Purity
99.24
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
ClC1=C(C)C(S(NC2=NC(CC(N3CCN(C)CC3)=O)=CS2)(=O)=O)=CC=C1
Molecular Formula
C17H21ClN4O3S2
Molecular Weight
428.96
Precautions
H302, H315, H319, H335
References & Citations
[1]Zhang L, et al. 11β-Hydroxysteroid dehydrogenase 1 inhibition attenuates collagen-induced arthritis. Int Immunopharmacol. 2013 Nov;17 (3) :489-94.|[2]Wang L, et al. BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice. PLoS One. 2012;7 (7) :e40056.|[3]11β-hydroxydehydrogenase 1 (11β-HSD1) Inhibitor in Development
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3

Popular Products